Allarity Therapeutics is now poised to run its DRP® testing in-house in a CLIA-certified laboratory environmentThe FDA requires that ...
The expanded pricing program provides greater savings for employers, healthcare providers, treatment facilities, ...
Many pathology groups have a common misunderstanding when expanding into molecular testing: underestimating the operational burden of later ...
What the successful completion of initial diagnostics product development program means for expansion into the CLIA ...
QuidelOrtho Corporation QDEL recently announced that it has been granted a CLIA Waiver by the FDA, which applies to its new Sofia 2 SARS Antigen+ FIA (fluorescent immunoassay). The Sofia 2 SARS ...
New regulations under the Clinical Laboratory Improvement Amendments (CLIA) introduced updated proficiency testing (PT) and PT referral rules that are now in effect. Although the regulations became ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results